Leave questions in the past.

Get answers as to why response to infliximab or aalimumab may be lost.

 

NEW PROMETHEUS® Anser™ ADA
is the first and only commercial test that can
measure both serum adalimumab levels and
antibodies to adalimumab.

Learn more 

PROMETHEUS® Anser™ IFX
measures both serum infliximab levels
and antibodies to infliximab.


Learn more 

 
 

Valuable information to help guide your treatment decisions for patients who lose response to adalimumab or infliximab.

 
©2013 Société des Produits Nestlé S.A. Vevey, Switzerland.  All rights reserved.  IFX12014  04/13
A Nestlé Health Science Company